Anthropic Acquires Coefficient Bio in Reported $400 Million Deal to Expand into AI-Driven Biotech

Anthropic has acquired stealth biotech startup Coefficient Bio in a deal reportedly valued at around $400 million, marking a notable step in its expansion beyond core AI models into life sciences.

The acquisition brings a specialized team focused on applying artificial intelligence to biological research and drug discovery, adding new capabilities to Anthropic’s growing healthcare and life sciences initiatives.

Coefficient Bio had been operating in stealth, with a research-driven approach centered on using AI to accelerate scientific discovery. Its integration into Anthropic suggests a shift toward building more domain-specific AI systems tailored for complex industries like biotechnology.

Rather than focusing solely on general-purpose AI, the move highlights a broader industry trend toward vertical applications—where AI is increasingly embedded into specialized workflows such as drug development and clinical research.

For Anthropic, the acquisition signals a long-term bet on AI’s role in scientific advancement, positioning the company to compete in a space where technology, data, and research are becoming deeply interconnected.

 

Source and Credits: TechCrunch